MENODYS and the Office of Sponsored Research, McGill University’s commercialization group, have signed an exclusive global licensing agreement for a medical technology developed by Prof. Satya Prakash, Head of the Biomedical Technology and Cell Therapy Research Laboratory, Dr. Mirko Gilardino, Plastic Surgeon and Assistant Professor of Craniofacial Surgery, and Jonathan Kanevsky, medical student, all of whom are affiliated with McGill University. This technological innovation, already covered by a provisional patent, is intended to reduce dermatological scars, including hypertrophic scars, and improve scar appearance.
MENODYS is a Canadian company specialized in the development, commercialization and distribution of medical technologies.
About McGill University
Founded in 1821, McGill University is Canada’s leading university. It has two campuses, 11 faculties, 11 professional schools, 300 programs of study and more than 37,800 students, including 8,300 at the graduate level. McGill University attracts students from over 150 countries, with 7,200 foreign students making up 20 percent of the student body. Almost half of the University’s students, including 6,200 francophones, claim a first language other than English.
To learn more: http://www.mcgill.ca